Management Team . . Board of Directors .
. Investors .
. Advisors
Meet our Management Team

Kim Albizati, Ph.D.
|

Junhua (Alex) Tao, Ph.D.
|

Tony
Tibbetts
|

Sanford J. Madigan, Ph.D.
|
Tony Tibbetts – Co-founder
and Chief Operations Officer
Prior to co-founding BioVerdant,
Mr. Tibbetts was the Head of the Materials Production Lab within
the Chemical Research and Development Group at Pfizer Global
R&D in La Jolla, CA.
While at Pfizer, he managed a group of scientists engaged in
the scaleup of drug substance candidates for use in clinical
trials. In 2002, Mr. Tibbetts was responsible for the renovation
of the original Agouron facility (acquired by Pfizer), tripling
its production capacity. Most recently, he designed the cGMP
kilo lab suite in Pfizer La Jolla, part of a $57MM, 150,000 square
foot facility to house the Pfizer Global Research and Development-Pharmaceutical
Sciences division. He has led numerous internal and external
drug substance campaigns used to drive clinical trials for a
variety of drug candidates. Mr. Tibbetts has extensive experience
in process development, GMP laboratory operation, quality assurance
principles and laboratory design and construction.
Prior to his responsibilities at Pfizer, Mr. Tibbetts was a member
of the Chemical Development Group at Agouron Pharmaceuticals and
was integral to the formation of the Materials Production Group.
Prior to joining Agouron, Mr. Tibbetts started his career as a
scientist at La Jolla Pharmaceutical Co. where he participated
in the discovery of an oligonucleotide-based drug candidate which
he then helped to move into clinical studies. He graduated from
the University of California, Santa Barbara after two years of
research with Prof. R. Daniel Little.
tony.tibbetts@bioverdant.com
|
|